PARD3 and cancer: Subsequent pseudotime analysis of the cancer cell population showed that PARD3 was preferentially enriched in cancer cells at early developmental stages but not in those at differentiated stages, further indicating the essential role of PARD3 as a driver of self-renewal maintenance in TICs.